Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KAPOR-DREZGIC, J.
Right arrow Articles by WHITESIDE, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KAPOR-DREZGIC, J.
Right arrow Articles by WHITESIDE, C.
J Am Soc Nephrol 10:1193-1203, 1999
© 1999 American Society of Nephrology


REGULAR ARTICLES

Effect of High Glucose on Mesangial Cell Protein Kinase C-{delta} and - is Polyol Pathway-Dependent

JOVANA KAPOR-DREZGIC*, XIAOPENG ZHOU*, TETSUYA BABAZONO{dagger}, JOHN A. DLUGOSZ*, THOMAS HOHMAN{ddagger} and CATHARINE WHITESIDE*

* Institute of Medical Science and Department of Medicine, University of Toronto, Canada
{dagger} Tokyo Women's Medical College, Tokyo, Japan
{ddagger} Wyeth-Ayerst Research, Princeton, New Jersey.

Correspondence to Dr. Catharine Whiteside, Medical Sciences Building, Room 7302, 1 King's College Circle, University of Toronto, Toronto, Ontario, Canada, M5S 1A8. Phone: 416-340-4140; Fax: 416-586-9827; E-mail: catharine.whiteside{at}utoronto.ca

Abstract. In diabetes mellitus, enhanced activity of mesangial cell protein kinase C (PKC) may contribute to nephropathy. The purpose of this study was to determine whether high glucose alters mesangial cell diacylglycerol-sensitive PKC-{alpha}, -ß2, -{delta}, and - content, cellular distribution, and activity through polyol pathway activation. Primary cultured rat mesangial cells (passage 10) were growth-arrested in 0.5% fetal bovine serum and cultured in 5.6 mM glucose (NG) or 30 mM glucose (HG) for 48 h, with or without the aldose reductase inhibitor tolrestat or ARI-509. PKC isoform content in total cell lysates, or cytosol, membrane (Triton X-soluble), and particulate (sodium dodecyl sulfate-soluble) fractions was analyzed by immunoblotting, and band density in HG was expressed as a percentage of corresponding NG values. In HG at 48 h, increased total PKC-{alpha} (222 ± 17% of NG, P < 0.001), -ß2 (209 ± 12%, P < 0.001), and - (195 ± 19%, P < 0.001) were observed. L-Glucose had no effect on total PKC isoform content. HG caused increased membrane- and particulate-associated PKC-{alpha} (257 ± 87 and 327 ± 66%, respectively, P < 0.05), membrane-associated PKC-{delta} (143 ± 10%, P < 0.05), and membrane-associated PKC- (186 ± 11%, P < 0.001), with no change in cytosol contents. The HG effects were not mimicked by L-glucose. In NG or HG, PKC-ß2 was not detected in the cytosol fraction, and membrane and particulate association were unchanged with phorbol ester stimulation. Confocal immunofluorescence imaging revealed that in HG, PKC-{alpha}, -{delta}, and - translocate to the nucleus and plasma membrane. Total PKC activity measured by in situ 32P-phosphorylation of the epidermal growth factor receptor substrate increased from 18 ± 1 pmol/min per mg cell protein in NG to 33 ± 3 pmol/min per mg cell protein in HG (P < 0.002 versus NG). In NG, tolrestat and ARI-509 exposure caused increased PKC activity, enhanced accumulation of total PKC-{alpha} and -ß2, with no change in total or fractional recovery of PKC-{delta} or -. In HG, tolrestat and ARI-509 prevented the increase in total PKC- and membrane-associated PKC-{delta} and -. It is concluded that within 48 h of HG, enhanced mesangial cell PKC activity is associated with accumulation and cellular redistribution of diacylglycerol-sensitive PKC isoforms, and that increased PKC- content and membrane-associated PKC-{delta} and - are dependent on polyol pathway activation.




This article has been cited by other articles:


Home page
Diabetes CareHome page
W.-Y. So, Y. Wang, M. C.Y. Ng, X. Yang, R. C.W. Ma, V. Lam, A. P.S. Kong, P. C.Y. Tong, and J. C.N. Chan
Aldose Reductase Genotypes and Cardiorenal Complications: An 8-year prospective analysis of 1,074 type 2 diabetic patients
Diabetes Care, November 1, 2008; 31(11): 2148 - 2153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Xia, H. Wang, S. Munk, H. Frecker, H. J. Goldberg, I. G. Fantus, and C. I. Whiteside
Reactive oxygen species, PKC-beta1, and PKC-{zeta} mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells
Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1280 - E1288.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Meier, J. Menne, J.-K. Park, and H. Haller
Nailing down PKC isoform specificity in diabetic nephropathy two's company, three's a crowd
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2421 - 2425.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Furlong, J. Crean, L. Thornton, R. O'Leary, M. Murphy, and F. Martin
Dysregulated intracellular signaling impairs CTGF-stimulated responses in human mesangial cells exposed to high extracellular glucose
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1691 - F1700.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Meier, J. Menne, J.-K. Park, M. Holtz, F. Gueler, T. Kirsch, M. Schiffer, M. Mengel, C. Lindschau, M. Leitges, et al.
Deletion of Protein Kinase C-{varepsilon} Signaling Pathway Induces Glomerulosclerosis and Tubulointerstitial Fibrosis In Vivo
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1190 - 1198.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Meier, J.-K. Park, D. Overheu, T. Kirsch, C. Lindschau, F. Gueler, M. Leitges, J. Menne, and H. Haller
Deletion of Protein Kinase C-{beta} Isoform In Vivo Reduces Renal Hypertrophy but Not Albuminuria in the Streptozotocin-Induced Diabetic Mouse Model
Diabetes, February 1, 2007; 56(2): 346 - 354.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. B. Marrero, A. K. Banes-Berceli, D. M. Stern, and D. C. Eaton
Role of the JAK/STAT signaling pathway in diabetic nephropathy
Am J Physiol Renal Physiol, April 1, 2006; 290(4): F762 - F768.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Frecker, S. Munk, H. Wang, and C. Whiteside
Mesangial cell-reduced Ca2+ signaling in high glucose is due to inactivation of phospholipase C-{beta}3 by protein kinase C
Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1078 - F1087.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
Endocr. Rev., December 1, 2004; 25(6): 971 - 1010.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Hua, S. Munk, H. Goldberg, I. G. Fantus, and C. I. Whiteside
High Glucose-suppressed Endothelin-1 Ca2+ Signaling via NADPH Oxidase and Diacylglycerol-sensitive Protein Kinase C Isozymes in Mesangial Cells
J. Biol. Chem., September 5, 2003; 278(36): 33951 - 33962.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Shaw, X. Wang, H. Redd, G. D. Alexander, C. M. Isales, and M. B. Marrero
High Glucose Augments the Angiotensin II-induced Activation of JAK2 in Vascular Smooth Muscle Cells via the Polyol Pathway
J. Biol. Chem., August 15, 2003; 278(33): 30634 - 30641.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
I. Talior, M. Yarkoni, N. Bashan, and H. Eldar-Finkelman
Increased glucose uptake promotes oxidative stress and PKC-{delta} activation in adipocytes of obese, insulin-resistant mice
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E295 - E302.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Haneda, D. Koya, M. Isono, and R. Kikkawa
Overview of Glucose Signaling in Mesangial Cells in Diabetic Nephropathy
J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1374 - 1382.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. T. Lee, H. Ha, M. Jung, H. Li, S. W. Hong, B. S. Cha, H. Chul Lee, and a. Y. Dong Cho
Delayed Treatment with Lithospermate B Attenuates Experimental Diabetic Renal Injury
J. Am. Soc. Nephrol., March 1, 2003; 14(3): 709 - 720.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. J. Kelly, Y. Zhang, C. Hepper, R. M. Gow, K. Jaworski, B. E. Kemp, J. L. Wilkinson-Berka, and R. E. Gilbert
Protein Kinase C {beta} Inhibition Attenuates the Progression of Experimental Diabetic Nephropathy in the Presence of Continued Hypertension
Diabetes, February 1, 2003; 52(2): 512 - 518.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. Wang, S. Shaw, F. Amiri, D. C. Eaton, and M. B. Marrero
Inhibition of the JAK/STAT Signaling Pathway Prevents the High Glucose-Induced Increase in TGF-{beta} and Fibronectin Synthesis in Mesangial Cells
Diabetes, December 1, 2002; 51(12): 3505 - 3509.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. I. Whiteside and J. A. Dlugosz
Mesangial cell protein kinase C isozyme activation in the diabetic milieu
Am J Physiol Renal Physiol, June 1, 2002; 282(6): F975 - F980.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Tsiani, P. Lekas, I. G. Fantus, J. Dlugosz, and C. Whiteside
High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor
Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E161 - E169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Kumar, K. S. Hawkins, M. A. Hannan, and M. B. Ganz
Activation of PKC-beta I in glomerular mesangial cells is associated with specific NF-kappa B subunit translocation
Am J Physiol Renal Physiol, October 1, 2001; 281(4): F613 - F619.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Hua, H. J. Goldberg, I.G. Fantus, and C. I. Whiteside
High Glucose-Enhanced Mesangial Cell Extracellular Signal-Regulated Protein Kinase Activation and {alpha}1(IV) Collagen Expression in Response to Endothelin-1: Role of Specific Protein Kinase C Isozymes
Diabetes, October 1, 2001; 50(10): 2376 - 2383.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. A. Dlugosz, S. Munk, J. Kapor-Drezgic, H. J. Goldberg, I. G. Fantus, J. W. Scholey, and C. I. Whiteside
Stretch-induced mesangial cell ERK1/ERK2 activation is enhanced in high glucose by decreased dephosphorylation
Am J Physiol Renal Physiol, October 1, 2000; 279(4): F688 - F697.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. Godbout, J. Pesavento, M. E. Hartman, S. R. Manson, and G. G. Freund
Methylglyoxal Enhances Cisplatin-induced Cytotoxicity by Activating Protein Kinase Cdelta
J. Biol. Chem., January 18, 2002; 277(4): 2554 - 2561.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. A. Dlugosz, S. Munk, E. Ispanovic, H. J. Goldberg, and C. I. Whiteside
Mesangial cell filamentous actin disassembly and hypocontractility in high glucose are mediated by PKC-zeta
Am J Physiol Renal Physiol, January 1, 2002; 282(1): F151 - F163.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP